Pfizer’s Oral COVID Drug Paxlovid Approved

By James Pereira On Feb 12, 2022

The pill called Paxlovid, a combination of two antiviral drugs, nirmatrelvir and ritonavir, will be the second oral drug available in Japan to treat mild Covid-19 symptoms.

The Ministry of Health Labour and Welfare is expected to approve the fast-tracking of Paxlovid soon.

Following the approval, the Japanese government plans to initially secure enough doses for 40,000 people.

The country has already agreed with the Japanese branch of the US pharmaceutical giant to acquire enough doses for 2 million people within the year.

Source: IANS

Stay connected with us on social media platform for instant update click here to join our T witter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Health News Click Here

For the latest news and updates, follow us on Google News.

Read original article here

Denial of responsibility! TechiLive.in is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.